Avinger (NASDAQ:AVGR) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR) in a research note issued to investors on Wednesday. The firm set a “hold” rating on the medical device company’s stock.

Avinger Price Performance

Shares of AVGR stock opened at $0.47 on Wednesday. Avinger has a 1-year low of $0.36 and a 1-year high of $4.37. The firm has a market cap of $1.57 million, a PE ratio of -0.04 and a beta of 1.09. The company has a 50-day moving average of $0.51 and a two-hundred day moving average of $0.75.

About Avinger

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.